Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2008-07-29
2008-07-29
Pak, Michael (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S141100
Reexamination Certificate
active
07404953
ABSTRACT:
The present invention provides an apoptosis inducer and a therapeutic agent for eosinophilic diseases which comprises, as an active ingredient, an antibody which reacts specifically with eosinophils and induces apoptosis of eosinophils; and a method for inducing eosinophil apoptosis using the antibody, and a method for specifically reducing or removing eosinophils in peripheral blood or tissues using the antibody.
REFERENCES:
patent: 6018032 (2000-01-01), Koike et al.
patent: 6465616 (2002-10-01), Lopez et al.
patent: 6538111 (2003-03-01), Koike et al.
patent: 7179464 (2007-02-01), Koike et al.
patent: 7238354 (2007-07-01), Koike et al.
patent: 2007/0048304 (2007-03-01), Koike et al.
patent: WO 98/47923 (1997-10-01), None
patent: WO 97/48418 (1997-12-01), None
H. Yasumichi et al., Int. Immunol., vol. 3, No. 2, pp. 135-139 (1991).
K. Takatsu et al., Zouketsu Inshi, vol. 2, No. 3, pp. 71-80 (1991) & English Translation of the related portion.
H-U Simon, et al., J. Immunol. pp. 3902-3908 (1997).
A.F. Lopez et al., J. Exp. Med., vol. 167, pp. 219-224 (1988).
M. Migita et al., Cell. Immunol., vol. 133, pp. 484-497 (1991).
M.E. Rothenberg et al., J. Immunol., vol. 143, pp. 2311-2316 (1989).
C.J. Sanderson, Blood, vol. 79, No. 12, pp. 3101-3109 (1992).
Simon H.U. Eosinophil apoptosis in allergic diseases—an emerging new issue. Clin Exp Allergy. Nov. 1998;28(11):1321-4.
Hanai Nobuo
Hosaka Emi
Koike Masamichi
Nakamura Kazuyasu
Shitara Kenya
Fitzpatrick ,Cella, Harper & Scinto
Kyowa Hakko Kogyo Co. Ltd.
Pak Michael
LandOfFree
Methods using eosinophil-specific apoptosis inducer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods using eosinophil-specific apoptosis inducer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods using eosinophil-specific apoptosis inducer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2807640